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Abstract
Background
Multidrug-resistant (MDR) E. coli with extended-spectrum β-lactamases (ESBLs) is becom-
ing endemic in health care settings around the world. Baseline data on virulence and antimi-
crobial resistance (AMR) of specific lineages of E. coli circulating in developing countries
like India is currently lacking.
Methods
Whole-genome sequencing was performed for 60 MDR E. coli isolates. The analysis was
performed at single nucleotide polymorphism (SNP) level resolution to identify the presence
of their virulence and AMR genes.
Results
Genome comparison revealed the presence of ST-131 global MDR and ST410 as emerg-
ing-MDR clades of E. coli in India. AMR gene profile for cephalosporin and carbapenem
resistance differed between the clades. Genotypes blaCTX-M-15 and blaNDM-5 were common
among cephalosporinases and carbapenemases, respectively. For aminoglycoside resis-
tance, rmtB was positive for 31.7% of the isolates, of which 95% were co-harboring carbape-
nemases. In addition, the FimH types and virulence gene profile positively correlated with
the SNP based phylogeny, and also revealed the evolution of MDR clones among the study
population with temporal accumulation of SNPs. The predominant clone was ST167 (blaNDM
lineage) followed by ST405 (global clone ST131 equivalent) and ST410 (fast spreading high
risk clone).
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Conclusions
This is the first report on the whole genome analysis of MDR E. coli lineages circulating in
India. Data from this study will provide public health agencies with baseline information on
AMR and virulent genes in pathogenic E. coli in the region.
Introduction
Escherichia coli is the leading cause of bloodstream infections (BSIs) [1] and other common
infections including urinary tract infections (UTIs). As an important commensal component
of the biosphere, E. coli colonizes the lower gut of animals and humans and gets released in the
environment.
Virulence of E. coli is driven by multiple factors including adhesins, toxins, siderophores,
lipopolysaccharide (LPS), capsule, and invasins [2]. It has recently been reported that a large
proportion of multi-drug resistant (MDR) E. coli carried by people is food acquired, especially
from farm animals [3]. Although most of the MDR E. coli are reported to be community
acquired, recently MDR E. coli, which produce extended-spectrum β-lactamases (ESBLs) have
been found to be endemic in health care settings [4,5].
Among MDR E. coli, AMR caused by ESBL is mainly due to the blaCTX-M family, particu-
larly blaCTX-M-15 and -14, compared to the less frequently observed blaSHV and blaOXA families
[6–8]. As per the literature, carbapenem resistance in E. coli is mostly mediated by blaOXA-48
[9], blaNDM and blaVIM genes [10]. Also, increasingly, resistance is being reported for fluoro-
quinolones and third- and fourth-generation cephalosporins and ST-131 predominates glob-
ally among such MDR E. coli strains [11].
This current study was aimed at identifying the predominant virulent and AMR genes in
MDR E. coli circulating in India. Core genome phylogeny was constructed using high quality
SNP profiles to analyse the genome wide factors associated with these genes in E. coli isolates
analyzed or sequenced.
Materials and methods
Isolates and identification
A total of 99257 specimens were received at the Department of Clinical Microbiology, Chris-
tian Medical College, Vellore, India for routine screening from BSI during the year 2006 to
2016. Isolation and identification of the organism were carried out using a standard protocol
as reported earlier [12]. Of the 1100 samples found culture positive for E. coli, 10% were resis-
tant to carbapenems, of which 60 MDR isolates were selected for further characterization.
Antimicrobial susceptibility testing (AST)
Disc diffusion. AST testing was carried out using the Kirby-Bauer disk diffusion method.
The antimicrobial agents tested were Amikacin (30 μg), netilmicin (30 μg), gentamycin
(10 μg), chloramphenicol (30 μg), ciprofloxacin (5 μg), cefotaxime (30 μg), cefoxitin (30 μg),
ceftazidime (30 μg), cefpodoxime (10 μg), piperacilllin-tazobactam (100/10 μg), cefoperazone-
sulbactam (75/30), imipenem (10 μg) and meropenem (10 μg), tigecycline (15 μg) and tetracy-
cline (30 μg) according to guidelines suggested by Clinical and Laboratory Standards Institute
(CLSI) M100-S27, 2017. Quality control strains (K. pneumoniae ATCC 700603, P. aeruginosa
ATCC 27853 and E. coli ATCC 25922) were used in all batches, as per the CLSI
recommendation.
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Minimum Inhibitory Concentration (MIC) for colistin. Colistin MICs for the studied
isolates were determined by broth microdilution and interpreted using CLSI 2017 breakpoint
recommendations. mcr-1 positive E. coli with the expected range 4–8 μg/ml, E. coli ATCC
25922 (0.25–2 μg/ml) and P. aeruginosa ATCC 27853 (0.5–4 μg/ml) were used as quality and
technical control (QC and TC) strains for colistin MIC determination.
Next generation sequencing and genome assembly
Genomic DNA was extracted using a QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany).
Whole genome sequencing (WGS) was performed using an Ion Torrent™ Personal Genome
Machine™ (PGM) sequencer (Life Technologies, Carlsbad, CA) with 400-bp read chemistry
according to the manufacturer’s instructions. Data were assembled with reference E. coli strain
(NC000913) using Assembler SPAdes v.5.0.0.0 embedded in Torrent Suite Server v.5.0.3.
Genome annotation
The assembled sequence was annotated using PATRIC, the bacterial bioinformatics database
and analysis resource (http://www.patricbrc.org), and NCBI Prokaryotic Genomes Automatic
Annotation Pipeline (PGAAP, http://www.ncbi.nlm.nih.gov/genomes/static/Pipeline.html).
Downstream analysis was performed using the CGE server (http://www.cbs.dtu.dk/services)
and PATRIC. The resistance gene profile was analysed using ResFinder 2.1 from the CGE
server (https://cge.cbs.dtu.dk//services/ResFinder/). The sequences were also screened for anti-
microbial resistance genes in the Antibiotic Resistance Genes Database (ARDB) and Compre-
hensive Antibiotic Resistance Database (CARD) through PATRIC. Virulence genes from the
genomes were identified using VirulenceFinder 2.0 (https://cge.cbs.dtu.dk/services/
VirulenceFinder/). Serotype of the isolates were identified using SerotypeFinder 1.1 (https://
cge.cbs.dtu.dk/services/SerotypeFinder/).
Genome based MLST analysis
Sequence types (STs) were analysed using multi-locus sequence typing (MLST) 1.8 tool
(https://cge.cbs.dtu.dk//services/MLST/). To visualize the possible evolutionary relationships
between isolates, STs of the study isolates and the globally reported strains were computed
using PHYLOViZ software v2.0 based on goeBURST algorithm. The study used Warwick
database for all sequence based MLST analysis of E. coli.
Genome comparison analyses
Gview, interactive genome viewer was used to compare the annotated E. coli genome arrange-
ments with the reference E. coli K12 genome (NC_000913) [13]. Core genome analysis was
performed using Roary: the Pan Genome Pipeline v3.11.2 from Sanger Institute [14]. The phy-
logenetic tree was constructed using the core SNPs using FastTree v2.1.10. To evaluate the
effect of recombination regions on the E. coli genomes, SNIPPY was performed to retrieve
core SNPs, that was followed by Genealogies Unbiased By recomBinations In Nucleotide
Sequences (Gubbins) algorithm [15]. The tree was constructed with midpoint rooting. Further,
the tree file was visualised and analysed in iTOL v4 (https://itol.embl.de/). A dendrogram rep-
resenting core vs pan genes was constructed using hierarchical cluster analysis with hclust
method in R.
This Whole Genome Shotgun project has been deposited at GenBank under the accession
numbers as mentioned in S1 Table. The version described in this manuscript is version 1.
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Ethical clearance
The study was approved by the Institutional Review Board and Ethical committee, Christian
Medical College, Vellore, India (IRB No.: 9540 dt 22-07-2015). All the samples were fully
anonymized before processing and since our study only utilised isolates received from routine
blood cultures, we did not require informed written consent from the patients.
Results
Antimicrobial susceptibility
All 60 E. coli isolates were resistant to carbapenems, quinolones, cephalosporins and beta-lac-
tamase inhibitors (S1 Table). Whereas all the isolates were susceptible to colistin except B7532
and B9021, which exhibited an MIC of 32 μg/ml.
Whole genome sequence analysis
Phylogeny of MDR E. coli. MLSTFinder revealed the different sequence types of the iso-
lates. The study isolates belonged to 6 clonal complexes with 14 different sequence types. Few
of the sequence types were observed to share same founder types revealing the evolution of
these strains. CC10 and CC 405 were the two major CCs observed with ST-167, ST-410 and
ST-405 as the common STs. Interestingly, nine isolates belonging to CC/ST-131 were identi-
fied, of which, all were of H-30 clade, except the isolate BA9313 (H-24).
E. coli genome comparison. Whole genome composition of 60 MDR E. coli was com-
pared with the E. coli K-12 reference genome which shows the region of differences between
these genomes (S1 Fig). A total of 2,518,792 SNPs were identified in all the analyzed genomes.
On minimum, 5957 and maximum, 74713 SNPs were identified in the study MDR E. coli
genomes when compared to the reference genome.
Core vs pan genome
Comparison between the core and pan genomes of 60 MDR E. coli isolates revealed 2258 core
genes across all 60 isolates among the 17944 total gene clusters. This includes 600 soft core
genes in 57 to 59 isolates, 3984 shell genes in 9 to 57 isolates and 11102 genes in less than 9 iso-
lates (Fig 1).
Serotype prediction. Serotypes were established from the whole genome data and O102:
H6 was the most common serotype (18.75%), followed by O89:H9 (15.6%), O8:H9 (12.5%),
O89:H5 (9.4%) and other serotypes (S1 Table).
Genetic virulence factors of MDR E. coli. Three common virulence gene profiles were
observed among the isolates as follows, i) iss, capU, gad, ii) ipfA, and iii) eilA, gad, air. The
FimH virulence typing revealed the types 5, 24, 27, 28, 30, 35, 54, 191 and 54-like in compari-
son to the fimH database.
Comparison of virulence and clonal traits. The virulence gene profiles of the 60 isolates
were compared to the FimH virulence types, MLST sequence type and SNP phylogeny. The
isolates clustered in two distinct groups including ST-131(H-30 clade), based on the virulence
genes identified (Fig 2). The sequence types were found to be tightly linked to the groups of
virulence gene profile and FimH types.
Antimicrobial resistance genetic determinants. ResFinder revealed the presence of mul-
tiple AMR genes in each of the MDR E. coli (Fig 3). Aminoglycoside and beta lactam resistance
genes were the most dominant. The most common aminoglycoside resistance genes were
aadA5 and aac(6’)lb-cr, followed by aadA2 and rmtB, while blaCTX-M-15 followed by blaNDM-5,
blaOXA-1 and blaTEM-1B were most prevalent among beta lactamases. Most of the isolates also
Genome-wide Comparison of Multidrug-Resistant Escherichia coli
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harboured mphA, catB4, sul1, tetB, dfrA17 and dfrA12. Interestingly, two isolates, B7532 and
B9021 carried mcr-1.1, which is responsible for plasmid-mediated colistin resistance. The two
isolates also showed phenotypic resistance to colistin with high MIC (>32 μg/ml). In addition,
the phenotypic resistance for other antimicrobials exhibited significant correlation (>80%)
with the presence of respective AMR genes.
Discussion
The increasing use of third-generation β-lactams and β-lactam inhibitors was accompanied
with increases in prevalence of the MDR phenotype among E. coli. The susceptibility profiles
noted in invasive E. coli isolates of our study were similar to the previously (2014–2016)
reported susceptibility to cefoxitin 53%, ceftazidime 33%, cefotaxime 26%, ceftriaxone 25%,
cefepime 29%, piperacillin tazobactam 66%, imipenem and meropenem 89%, aztreonam 36%,
ciprofloxacin 19%, levofloxavin 23%, and amikacin 91% [16]. Among these, about 64% of E.
coli were found to be ESBL producers.
On genotypic characterization of MDR E. coli isolates, the increasing frequency of antimi-
crobial resistance in clinical E. coli isolates was found to be associated with blaCTX-M, blaNDM,
and mcr genes. In our study, multiple AMR genes for beta lactams, carbapenems, fluoroquino-
lones, tetracycline, aminoglycosides and colistin were identified. The presence of genotypic
AMR genes correlated well with phenotypic expression for beta lactams, carbapenems, fluoro-
quinolones and tetracycline. Plasmids IncFII majorly carried AMR genes blaCTX-M-15, blaNDM-
5, aadA2, rmtB, sul1, drfA12, erm(B) and tetA, while IncFI plasmids carried mostly aadA5,
sul2, dfrA17, mph(A) and tetB genes. Results from plasmid analysis of the study isolates were
previously published elsewhere [17].
The MDR E. coli isolates phylogenetically grouped into four major clades: ST167, ST410,
ST405 and ST131. Variant blaNDM-5, responsible for carbapenem resistance was common in
Fig 1. Pan genome vs core genome comparison depicting number of pan genes and conserved genes (A), Distribution of core genes, soft core genes and
pan genes among the 60 MDR E. coli isolates from BSI (B).
https://doi.org/10.1371/journal.pone.0220428.g001
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comparison to other blaNDM variants. The blaNDM positive isolates belonging to ST410 and
ST405 harboured only the blaNDM-5 variant, whereas ST167 and ST131 isolates had blaNDM-4
and blaNDM-1 respectively, in addition to blaNDM-5. Interestingly only two isolates out of 60
MDR E. coli had blaNDM-1, while it is still common among other species of MDR clinical path-
ogens in India [18]. From Hong Kong, a previous report identified blaNDM-1 as common
among E. coli though the sample size was lesser [19], whereas in central China, blaNDM-1 and
blaNDM-5 occurrence in E. coli has been reported in equal numbers [20].
Globally, blaOXA-48 type were the most commonly reported carbapenemases among E. coli
[21], followed by blaNDM [22], blaIMP [23] and blaKPC [24]. Studies have reported occurrence
of blaOXA-48 from as low as 3% to 22% [25, 9]. In contrast, a previous report from India on car-
bapenem-resistant clinical E. coli isolates from 2013 and 2015 has shown that blaNDM was com-
mon among carbapenemases in E. coli (70%), followed by blaOXA-48 (24%) and blaVIM (17%).
Co-occurences of blaNDM along with blaOXA (5%) and blaVIM (17%) have also been reported
[26]. Similar results were seen in our study and the combinations observed were only
blaNDM+blaOXA-1. Though, blaOXA-181 was rare in combination with blaNDM (n = 1). These
Fig 2. SNP phylogeny based comparison of genetic virulence traits observed in MDR E. coli strains. Sequence types, virulence gene profile, O and H
antigens and Fim-H types are shown next to the tree.
https://doi.org/10.1371/journal.pone.0220428.g002
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observations confirm that blaNDM is prevalent among E. coli followed by blaOXA in India,
which is otherwise the most prevalent elsewhere.
There has been a global concern on aminoglycoside resistance in Gram-negatives. Acquired
16S-RMTases are known to confer extremely high level of aminoglycoside resistance, due to
which key aminoglycosides including gentamicin, tobramycin, and amikacin are ineffective
against carbapenem resistant strains [27]. Accordingly, plazomicin, a new aminoglycoside
agent identified to combat against carbapenem-resistant Enterobacteriaceae, was found inac-
tive if the isolates co-produced 16S-RMTases [28]. In this study, ~ 95% of the RMTase positive
E. coli co-harboured carbapenemases, which worryingly contributes to the already high bur-
den of carbapenem resistance. Similar to our study, Taylor et al. [29] and Poirel et al. [30] have
reported 83.1% and 45.4% co-occurrence of carbapenemases in 16S RMTase producing Enter-
obacteriaceae, respectively.
Our study shows that, for cephalosporin resistance, the isolates from ST131 and ST405
clades carried blaCTX-M-15 in 100% and 92% of their respective clades, whereas ST167 and
ST410 isolates carried 18% and 43% blaCMY genes in addition to 63% and 100% blaCTX-M-15.
However, 54.34% blaCTX-M was reported previously in ESBL positive isolates from India [31].
Among the study isolates, ST167 carried significantly (P<0.05) lesser blaCTX-M-15 in compari-
son to other clades. Similarly, ST167 and ST410 carried blaCMY in addition for cephalosporin
resistance which was not seen in ST131 and ST405. Recently, plasmid-mediated colistin resis-
tance is being increasingly reported in E. coli [32–34]. This study also observed two isolates
(B7532, B9021) with mcr-1.1 expressing high MIC of>32 μg/ml to colistin and both the iso-
lates, from the same time period and ward, were closely related with same sequence type
(ST624). After this observation made in 2007 strains, there have been no reports of mcr.
Fig 3. Antimicrobial resistance genes observed in MDR E. coli compared to the SNP based phylogeny. Depicting prevalence of blaNDM-5 among
carbapenemases and blaCTX-M-15 among cephalosporinases.
https://doi.org/10.1371/journal.pone.0220428.g003
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The antimicrobial susceptibility of E. coli has been shown to vary geographically [35].
Among the different clonal groups observed elsewhere, E. coli ST131 was previously reported to
be most commonly associated with community acquired infection [36–37], which recently
were highly associated with healthcare settings. Also, ST131 was reported earlier as the predom-
inant lineage carrying blaCTX-M-15 and other ESBLs. Most of the MDR E. coli carrying blaCTX-M-
15 from different countries in Europe and North America were homogenously grouped into the
E. coli O25:H4-ST131 [6,36–37]. In our study, 87% of the isolates carried blaCTX-M-15, among
various STs, with only nine isolates of ST131. Among the observed STs in this study, blaCTX-M-
15 was previously reported for its association with ST617, ST405 and ST131 [37].
Though ST131 clones were predominantly reported worldwide, the STs observed in our
study were striking for clustering in distinct phylogenetic lineages. ST167 was previously
reported for its ability to carry blaNDM genes in China [38–40]. ST405 has been known as
another global clonal group similar to ST131 [41] and has been reported to carry blaNDM genes
in hospital settings [42], in addition to blaKPC-2 [43]. ST405 was reported as a lineage, carry-
ing fluoroquinolone resistance in Japan [41]. Recently, ST410 was reported as a possible inter-
national high risk clone with B2/H24R, B3/H24Rx, and B4/H24RxC AMR clades. B3/H24Rx
was reported to be evolved by acquisition of the blaCTX-M-15 and an IncFII plasmid. B4/
H24RxC emerged by acquiring IncX3 plasmid with blaOXA-181 known for carbapenem resis-
tance, which further acquired blaNDM-5, on a conserved IncFII plasmid [44]. In this study, all
ST410 isolates (n = 7) harboured blaCTX-M-15 gene, while only B25762, BV643, B12243 and
B32605 had IncFII plasmids and blaNDM-5 (B3/H24RxC). B12243, in addition harboured
IncX3 with blaOXA-181 (B4/H24RxC), while BA22372 and BA9615 had only blaOXA-181 in
IncX3 plasmid (B4/H24RxC).
Virulence genes observed among the E. coli isolates varied according to the different clades
observed. The comparison of the virulence gene type with SNP based phylogeny revealed the
acquisition and deletion of virulence genes. Genes iss, capU and gad were observed in ST167
clade. ST131 possessed iha, sat, cnfl and senB, in addition to iss and gad. ST131 strains in our
study have lost the capU genes. Further, ST405 clade also lost iss and gained eilA and air genes
with FimH type 29. Few isolates of ST405 retained iha and sat genes belonging to FimH 27
type within ST405. ST410 (FimH 24) that predominantly had ipfA gene, on the contrary, lost
all other genes, except gad gene in two isolates. Overall, gad gene served as backbone for
ST167, ST131 and ST405 clades, while ipfA was consistent in ST410. Ours is the first study that
compares the evolution of virulence pattern with phylogeny, which explains the emergence of
a stable clinical virulent phenotype.
FimH, that had been reported as a major candidate for the development of a vaccine against
pathogenic E. coli [45] is responsible for producing mannose-sensitive bacterial adhesion [45].
Though high nucleotide conservation of>98% was observed in fimH alleles, minor sequence
differences have been reported to correlate with differential binding and adhesion phenotypes
[46]. Fim-H types in our study correlated well with the STs.
Our study shows that with a SNPs based phylogeny, higher discrimination between the clin-
ical MDR E. coli isolates is apparent. Therefore, more such studies with integrated approach to
analysing pathogenic E. coli in India are required to fully understand and follow the dynamic
virulence and AMR landscape of this rapidly evolving group of pathogens.
Conclusions
To the best of our knowledge, this is the first report on SNP phylogeny in comparison with
AMR and virulence traits in E. coli in India. The study revealed the prevalence of blaNDM-5
among the clades ST131, ST405 and ST410 clades. blaCTX-M-15 was responsible for
Genome-wide Comparison of Multidrug-Resistant Escherichia coli
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cephalosporin resistance in ST131 and ST405 clades whereas, ST167 and ST410 carried both
blaCTX-M-15 and blaCMY genes. For aminoglycoside resistance, rmtB was positive for 31.7% of
the isolates, of which 30% were co-harbouring carbapenemases. The FimH types and virulence
gene profile positively correlated with the SNP based phylogeny. However the predominant
ST131 epidemic clone was smaller in our study population while ST167 and ST405 clones with
multiple AMR genes were predominant. Further larger studies are needed to rule out any pos-
sible bias. Isolates with iss, capU and gad virulence genes were the major type. Moreover, SNP
based phylogeny revealed evolution of the MDR clones among the study population, which
suggests that continuous WGS level molecular surveillance would be necessary to keep track of
the spread of MDR clones in India.
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